SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Giants19675/13/2024 8:27:34 AM
   of 120394
 
$INBS Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights

Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024

Cash and cash equivalents as of March 31, 2024, was $9.40 million

Commenced FDA 510(k) clinical studies plan with Cliantha Research and remains on track for planned submission by the end of 2024 and planned entry into the US in 2025

Secured 26 new customer accounts throughout the quarter, representing a combined headcount of approximately 16,779 employees

https://www.globenewswire.com/news-release/2024/05/08/2877827/0/en/Intelligent-Bio-Solutions-Inc-Reports-Fiscal-2024-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext